Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in humanplasma by liquid chromatographic-mass spectrometry
M. Yao et Nr. Srinivas, Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in humanplasma by liquid chromatographic-mass spectrometry, BIOMED CHRO, 14(2), 2000, pp. 106-112
A rapid and sensitive LC-MS assay was developed and validated for the simul
taneous determination of d7-nefazodone (d7-NEF), nefazodone (NEF), d7-hydro
xynefazodone (d7-OH-NEF), hydroxynefazodone (ON-NEF), m-chlorophenylpiperaz
ine (mCPP), and triazole-dione (Dione) in human plasma using trazodone (TRZ
) as the internal standard (IS). A 0. I mt aliquot of the plasma sample was
precipitated with 0.1 mt of acetonitrile and vortexed for 2 min. After cen
trifugation. 50 mu L of supernatant was mixed with 100 mu L of 10 mM ammoni
um formate (pH = 4.0), and a 50 mu L aliquot was injected onto a BDS Hypers
il C18 column at a flow rate of 0.3 mL/min. The mobile phase consisting of
10 mM ammonium formate (pH = 4) and acetonitrile, 55:45 v/v, was used in an
isocratic system. The mass spectrometer was programmed to admit the proton
ated molecules at m/z 477.2 (d7-NEF), 493.3 (d7-OH-NEF), 197.0 (mCPP), 372.
0 (IS), 470.4 (NEF), 458.0 (Dione) and 486.2 (OH-NEF). Standard curves were
linear (r(2) greater than or equal to 0.994) over the concentration range
of 4-1000 ng/mL for Dione and 2-500 ng/mL for all other analytes. The lowes
t standard concentrations were the lower limits of quantitation for each an
alyte. The mean predicted quality control concentrations for all analytes d
eviated by less than 14.3% from the corresponding nominal values; the intra
-assay and inter-assay precisions of the assay for all analytes were within
10.5% relative standard deviation. All analytes including the internal sta
ndard were stable in the injection solvent at room temperature for at least
24 h. The extraction recovery of the various analytes ranged from 79.2 to
109.1%. The validated assay was applied to the analysis of clinical samples
obtained from a human subject who simultaneously received d7-NEF and NEF o
rally. Copyright (C) 2000 John Wiley & Sons, Ltd.